These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32595720)

  • 21. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visceral leishmaniasis and haemophagocytic syndrome in an Omani child.
    Al Sineidi K; Wali YA; Pathare AV; Al Lamki Z
    J Sci Res Med Sci; 2002 Apr; 4(1-2):45-8. PubMed ID: 24019726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany - a case report.
    Adamczick C; Dierig A; Welzel T; Schifferli A; Blum J; Ritz N
    BMC Infect Dis; 2018 Oct; 18(1):495. PubMed ID: 30285634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral Leishmaniasis and Glomerulonephritis: A Case Report.
    Alwazzeh MJ; Alhashimalsayed ZH
    Saudi J Med Med Sci; 2019; 7(1):40-43. PubMed ID: 30787856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hematologic characteristics of leishmaniasis].
    Belić A; Pejin D; Stefanović N; Spasojević J; Durković D
    Med Pregl; 2000; 53(1-2):89-91. PubMed ID: 10953559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From unexplained fever to visceral leishmaniasis--a case report].
    Marković I; Gudelj-Gracanin A; Culo MI; Stoos-Veić T; Vicković N; Desnica B; Morović-Vergles J
    Lijec Vjesn; 2014; 136(1-2):22-4. PubMed ID: 24720151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
    BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].
    Landmann E; Bogdan C; Donhauser N; Artlich A; Staude B; Gortner L
    Klin Padiatr; 2000; 212(5):266-7. PubMed ID: 11048286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imported visceral leishmaniasis - unexpected bone marrow diagnosis in a patient with fever, pancytopenia, and splenomegaly.
    Gallina V; Binazzi R; Golemi A; Farsad M; Weiss G; Wiedermann CJ
    Am J Blood Res; 2014; 4(2):101-5. PubMed ID: 25755910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fever, hepatosplenomegaly and pancytopenia in a patient living in the Mediterranean region.
    Büyükaşik Y; Ileri NS; Haznedaroğlu IC; Demiroğlu H; Dündar S
    Postgrad Med J; 1998 Apr; 74(870):237-9. PubMed ID: 9683980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis masquerading as chronic liver disease.
    Prakash A; Singh NP; Sridhara G; Malhotra V; Makhija A; Garg D; Pathania A; Agarwal SK
    J Assoc Physicians India; 2006 Nov; 54():893-4. PubMed ID: 17249262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute fulminant visceral leishmaniasis in children--a report of two cases.
    Pahwa R; Gupta SK; Singh T; Nigam S
    Indian J Pathol Microbiol; 2004 Jul; 47(3):428-30. PubMed ID: 16295448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two cases of visceral leishmaniasis from Kahramanmaraş, Turkey].
    Karaoğlan İ; Ekşi F; Haydaroğlu Şahin H; Pehlivan M; Tekin Şahin S; Keçik Boşnak V; Bilici M; Namıduru M; Karslıgil T
    Mikrobiyol Bul; 2015 Apr; 49(2):295-8. PubMed ID: 26167831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-generation sequencing technology for diagnosis and efficacy evaluation of a patient with visceral leishmaniasis: A case report.
    Lin ZN; Sun YC; Wang JP; Lai YL; Sheng LX
    World J Clin Cases; 2021 Nov; 9(32):9903-9910. PubMed ID: 34877329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kala-azar in a four-year-old child 18 months after brief exposure in Malta.
    Ornvold K; Carstensen H; Magnussen P; Nielsen MH; Pedersen FK
    Acta Paediatr Scand; 1989 Jul; 78(4):650-2. PubMed ID: 2551125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case report of visceral leishmaniasis in Singapore.
    Abraham G; Leo YS; Singh M; Wong SY
    Ann Acad Med Singap; 1997 Sep; 26(5):713-6. PubMed ID: 9494684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kala-Azar and leukemia: A rare association.
    Bay A; Aktekin EH; Ekşi F; Özcan M
    Turk Pediatri Ars; 2018 Mar; 53(1):45-47. PubMed ID: 30083074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis.
    Makaritsis KP; Gatselis NK; Ioannou M; Petinaki E; Dalekos GN
    Int J Infect Dis; 2009 Jul; 13(4):e157-60. PubMed ID: 19008139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.